396 related articles for article (PubMed ID: 9539744)
1. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways.
Novak A; Hsu SC; Leung-Hagesteijn C; Radeva G; Papkoff J; Montesano R; Roskelley C; Grosschedl R; Dedhar S
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4374-9. PubMed ID: 9539744
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
3. Signaling through beta-catenin and Lef/Tcf.
Novak A; Dedhar S
Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
[TBL] [Abstract][Full Text] [Related]
4. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
[TBL] [Abstract][Full Text] [Related]
5. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.
Oloumi A; McPhee T; Dedhar S
Biochim Biophys Acta; 2004 Apr; 1691(1):1-15. PubMed ID: 15053919
[TBL] [Abstract][Full Text] [Related]
6. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG
J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780
[TBL] [Abstract][Full Text] [Related]
7. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of integrin-linked kinase activation in podocyte damage.
Teixeira Vde P; Blattner SM; Li M; Anders HJ; Cohen CD; Edenhofer I; Calvaresi N; Merkle M; Rastaldi MP; Kretzler M
Kidney Int; 2005 Feb; 67(2):514-23. PubMed ID: 15673299
[TBL] [Abstract][Full Text] [Related]
9. Integrin-linked kinase (ILK): a "hot" therapeutic target.
Yoganathan TN; Costello P; Chen X; Jabali M; Yan J; Leung D; Zhang Z; Yee A; Dedhar S; Sanghera J
Biochem Pharmacol; 2000 Oct; 60(8):1115-9. PubMed ID: 11007949
[TBL] [Abstract][Full Text] [Related]
10. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
11. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
12. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
Oloumi A; Syam S; Dedhar S
Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
[TBL] [Abstract][Full Text] [Related]
14. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
15. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.
Delcommenne M; Tan C; Gray V; Rue L; Woodgett J; Dedhar S
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11211-6. PubMed ID: 9736715
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
Easwaran V; Song V; Polakis P; Byers S
J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
[TBL] [Abstract][Full Text] [Related]
18. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.
Wong MH; Huelsken J; Birchmeier W; Gordon JI
J Biol Chem; 2002 May; 277(18):15843-50. PubMed ID: 11854293
[TBL] [Abstract][Full Text] [Related]
19. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
Naves MA; Requião-Moura LR; Soares MF; Silva-Júnior JA; Mastroianni-Kirsztajn G; Teixeira VP
J Nephrol; 2012; 25(3):401-9. PubMed ID: 21928230
[TBL] [Abstract][Full Text] [Related]
20. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
